Healthcare & Pharmaceutics

135 ABA Journal Healthcare & Pharmaceutics articles.

Do courts lack info about medication-assisted treatment as an option for defendants with opioid addiction?

Judges aren’t doctors, so should they make decisions on whether medication-assisted treatment is appropriate for defendants addicted to opioids? Whether a defendant can be on probation or in drug court while receiving medication-assisted treatment can differ by judge, including those in the same jurisdiction.

ABA amicus brief urges SCOTUS to follow precedent in Louisiana abortion case
The ABA filed an amicus brief with the U.S. Supreme Court on Monday that urges the justices to reverse an appellate decision upholding a Louisiana law that requires physicians who perform abortions to have admitting privileges at a local hospital.
Judge accused of ‘partisan glee’ after $8B verdict says high-five allegations were fabricated
A Philadelphia judge accused of showing “partisan glee” and high-fiving jurors after they awarded $8 billion in a Risperdal case denied the allegation Wednesday and focused on the lawyers who made the accusation.
Government fights health care fraud with aid of data analytics
The government is using data analytics to spot trends in Medicare and Medicaid billing patterns that point to possible health care fraud.
Motion accuses judge of ‘partisan glee’ after $8B Risperdal verdict
A Philadelphia judge is accused of showing “partisan glee” after jurors awarded $8 billion in punitive damages in a case brought by a man who contended his childhood use of the drug Risperdal had caused him to grow breasts.
4 drug companies agree to $260M opioid settlement with 2 Ohio counties
Four drug companies have agreed to a $260 million opioid settlement with two Ohio counties—Cuyahoga and Summit counties—that contended that the companies misled the public in their opioid marketing and created a public nuisance that endangered health.
Oops! Judge mistakenly added three zeroes to part of opioid award
An Oklahoma judge who ordered Johnson & Johnson to pay $572 million for its role in the state’s opioid epidemic admitted in court on Tuesday that he made a $107 million math error.
Afternoon Briefs: Arrests for low-level crimes plummet; inmate complains about commissary-money restitution

Arrests for low-level crimes plummet in some cities and states

In some cities and states, arrests are plummeting for minor crimes such as disorderly conduct, loitering, prostitution and driving violations.…

Afternoon Briefs: Jurors award $8B in Rispderdal case; most minority partners have nonequity status

Jurors award $8B in punitive damages in Risperdal case

Jurors in Philadelphia found Johnson & Johnson liable for $8 billion in punitive damages Tuesday in a case brought by a…

Afternoon Briefs: Justice for bilked law firms; conviction upheld for driving lawn mower while drunk

Belgian man to plead guilty in scheme to bilk US law firms and charities

Belgian national Aref Said has notified a Massachusetts federal court that he plans to plead guilty…

$572M verdict against Johnson & Johnson in opioid suit is based on Oklahoma’s unusual public nuisance law
An Oklahoma judge ruled Monday that Johnson & Johnson is liable for $572 million for the public nuisance it created when it engaged in a marketing campaign that promoted opioid use.
Federal judge blocks HHS rule requiring drugmakers to disclose prices in TV ads
A federal judge in Washington, D.C., has vacated an agency rule that required drugmakers to disclose the list price of prescriptions in TV advertising.
Founder of online abortion-pill service says she won’t turn anyone away, despite FDA warning

A Dutch doctor who founded an online abortion-pill service called AID Access is striking a defiant tone after the Food and Drug Administration sent her a warning letter telling her…

Purdue Pharma reaches $270M settlement with Oklahoma in opioid epidemic suit

Purdue Pharma and its owners have agreed to a $270 million settlement with Oklahoma in the state’s lawsuit claiming OxyContin contributed to an opioid epidemic, according to multiple publications.


Sellers of blood-thinner drug to settle about 25,000 suits for $775M

The sellers of the blood thinner Xarelto have agreed to pay $775 million to settle about 25,000 lawsuits claiming the companies failed to warn the drug can cause potentially fatal…

Read more ...